![Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial - The Lancet Infectious Diseases Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/b2d9ed1e-293b-4250-9672-c43b6ab79d5a/gr1.gif)
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial - The Lancet Infectious Diseases
![Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? | ACS Infectious Diseases Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.0c00478/asset/images/medium/id0c00478_0009.gif)
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? | ACS Infectious Diseases
![Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial. - eClinicalMedicine Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial. - eClinicalMedicine](https://www.thelancet.com/cms/attachment/bd3d0191-6065-43f6-b995-ca53bd758713/gr1.jpg)
Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial. - eClinicalMedicine
![Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial | European Respiratory Society Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial | European Respiratory Society](https://erj.ersjournals.com/sites/default/files/highwire/erj/58/1.cover-source.jpg)
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial | European Respiratory Society
![Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial | European Respiratory Society Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial | European Respiratory Society](https://erj.ersjournals.com/content/erj/58/1/2003725/F2.large.jpg)
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial | European Respiratory Society
![A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19 - ScienceDirect A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299920308402-gr1.jpg)